Literature DB >> 8215804

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

M Laruelle1, A Abi-Dargham, M F Casanova, R Toti, D R Weinberger, J E Kleinman.   

Abstract

BACKGROUND: This study investigates serotonergic receptors in prefrontal cortex of patients with schizophrenia.
METHODS: We measured serotonin 2 receptors and serotonin uptake sites in prefrontal and occipital cortex of schizophrenics, patients with chronic schizoaffective disorders, nonpsychotic suicides, and controls. Diagnoses were established according to DSM-III-R criteria from medical chart reviews.
RESULTS: In prefrontal cortex, serotonin 2 density was decreased in chronic psychotics dying of natural causes, as opposed to psychotics dying of suicide, controls, and nonpsychotic suicide victims. Serotonin uptake sites were decreased in prefrontal cortex of schizophrenics and nonpsychotic suicides, but not in patients with schizoaffective disorder. None of the observed differences were clearly related to antemortem pharmacological treatments. In the occipital pole, no differences were found among the groups.
CONCLUSIONS: Selective prefrontal alterations of both presynaptic and postsynaptic serotonin receptor densities are present in at least some schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215804     DOI: 10.1001/archpsyc.1993.01820220066007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  31 in total

1.  Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.

Authors:  Gerard J Marek
Journal:  Eur Neuropsychopharmacol       Date:  2008-02-21       Impact factor: 4.600

2.  What can post-mortem studies tell us about the pathoetiology of suicide?

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi
Journal:  Future Neurol       Date:  2010-09

3.  Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.

Authors:  J J Mann; R A Henteleff; T F Lagattuta; J A Perper; S Li; V Arango
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

Authors:  Mark D Underwood; Suham A Kassir; Mihran J Bakalian; Hanga Galfalvy; J John Mann; Victoria Arango
Journal:  Int J Neuropsychopharmacol       Date:  2011-05-09       Impact factor: 5.176

5.  Serotonin transport kinetics correlated between human platelets and brain synaptosomes.

Authors:  Jeffrey L Rausch; Maria E Johnson; Junqing Li; Julian Hutcheson; Benjamin M Carr; Katina M Corley; Amanda B Gowans; Joseph Smith
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

6.  Whole-transcriptome microarray analysis reveals regulation of Rab4 by RBM5 in neurons.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek
Journal:  Neuroscience       Date:  2017-08-15       Impact factor: 3.590

7.  Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study.

Authors:  N R Cutler; J J Sramek
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 8.  Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

Authors:  G Fink; B E Sumner; R Rosie; O Grace; J P Quinn
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

9.  Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.

Authors:  L Naylor; B Dean; K Opeskin; G Pavey; C Hill; N Keks; D Copolov
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 10.  Biological basis of suicide and suicidal behavior.

Authors:  Ghanshyam N Pandey
Journal:  Bipolar Disord       Date:  2013-06-15       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.